Think Research Corporation (THNK.V)
| Previous Close | 0.8000 |
| Open | 0.8500 |
| Bid | 0.8500 x N/A |
| Ask | 0.8700 x N/A |
| Day's Range | 0.8200 - 0.8700 |
| 52 Week Range | 0.4100 - 2.4800 |
| Volume | |
| Avg. Volume | 50,040 |
| Market Cap | 51.243M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5890 |
| Earnings Date | Aug 22, 2022 - Aug 26, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.91 |
- CNW Group
Think Research Announces Contract with St. George's University Hospitals NHS Foundation Trust to Deliver Nursing Care Plans
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company"), a healthcare technology company focused on transforming healthcare through knowledge-based digital health software solutions, is pleased to announce it has signed a contract to provide Care Pathways nursing content to St. George's University Hospitals NHS Foundation Trust, a major teaching hospital in London, England and part of the largest public healthcare system in the world.
- CNW Group
Think Research to Participate in 3rd Annual TSX Venture Growth Capital Event On July 8 in Kelowna BC
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that at the invitation-only event Management will be speaking directly to small-cap investors regarding progress made over the past year.
- CNW Group
Think Research Signs 3-year SaaS Contract with Top U.S. Pharmacy Retailer
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that it has been contracted by a major U.S.-based pharmacy to deliver business intelligence and support solutions to more than 1700 pharmacies servicing 5.5 million patients throughout the United States. This contract is a direct result of the acquisition and subsequent integration of Pharmapod Ltd. ("Pharm
